Correlation Between Zoetis and Vir Biotechnology
Can any of the company-specific risk be diversified away by investing in both Zoetis and Vir Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zoetis and Vir Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zoetis Inc and Vir Biotechnology, you can compare the effects of market volatilities on Zoetis and Vir Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zoetis with a short position of Vir Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zoetis and Vir Biotechnology.
Diversification Opportunities for Zoetis and Vir Biotechnology
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Zoetis and Vir is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Zoetis Inc and Vir Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vir Biotechnology and Zoetis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zoetis Inc are associated (or correlated) with Vir Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vir Biotechnology has no effect on the direction of Zoetis i.e., Zoetis and Vir Biotechnology go up and down completely randomly.
Pair Corralation between Zoetis and Vir Biotechnology
Considering the 90-day investment horizon Zoetis Inc is expected to generate 0.33 times more return on investment than Vir Biotechnology. However, Zoetis Inc is 3.06 times less risky than Vir Biotechnology. It trades about -0.12 of its potential returns per unit of risk. Vir Biotechnology is currently generating about -0.14 per unit of risk. If you would invest 18,195 in Zoetis Inc on September 2, 2024 and sell it today you would lose (670.00) from holding Zoetis Inc or give up 3.68% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Zoetis Inc vs. Vir Biotechnology
Performance |
| Timeline |
| Zoetis Inc |
| Vir Biotechnology |
Zoetis and Vir Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zoetis and Vir Biotechnology
The main advantage of trading using opposite Zoetis and Vir Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zoetis position performs unexpectedly, Vir Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vir Biotechnology will offset losses from the drop in Vir Biotechnology's long position.| Zoetis vs. Emergent Biosolutions | Zoetis vs. Bausch Health Companies | Zoetis vs. Neurocrine Biosciences | Zoetis vs. Teva Pharma Industries |
| Vir Biotechnology vs. CureVac NV | Vir Biotechnology vs. Krystal Biotech | Vir Biotechnology vs. Propanc Biopharma | Vir Biotechnology vs. Blueprint Medicines Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |